The FDA has issued a warning letter to a Florida CMO that it says has dirty equipment, poor storage methods and questionable record keeping about whether drugs were effective.
Andapharm, LLC Receives FDA Warning Letter
ANDAPharm News Full Screen View
Market Place
Share
